CAR-T cells and bispecific antibodies have advanced our therapeutic armamentarium for haematological malignancies. The programme of the ESH 2nd How I Manage "CAR-T Therapies and Bispecific Antibodies for my patients"" conference aims to provide an overview of the benefits and risks of currently available therapies for acute lymphoblastic leukaemia, lymphoma and multiple myeloma. Special focus will be placed on the advantages and disadvantages of bispecific antibodies vs. cellular therapies (including T cells, NK cells and transplant strategies). Future perspectives regarding applications in other haematological malignancies and in solid tumours will also be discussed. Chairs: Ulrich Jäger, Marie José Kersten, Loretta Nastoupil

Date: Friday 29 September - Sunday 1 October 2023
Venue: Vienna House Andels' Berlin, Germany

CAR-T cells and bispecific antibodies have advanced our therapeutic armamentarium for haematological malignancies. The programme of this ESH conference aims to provide an overview of the benefits and risks of currently available therapies for acute lymphoblastic leukaemia, lymphoma and multiple myeloma. Special focus will be placed on the advantages and disadvantages of bispecific antibodies vs. cellular therapies (including T cells, NK cells and transplant strategies). Future perspectives regarding applications in other haematological malignancies and in solid tumours will also be discussed.

The format of the meeting is based on the analysis and discussion of clinical case studies. It will adopt a problem-solving approach, addressing practical considerations and guidelines. Emphasis will be placed on open discussion, including a maximum level of interaction between faculty and registered participants. In addition to the scientific and medical issues addressed during the conference, the questions of affordability of and access to these novel expensive treatments will be tackled by medical experts, representatives of patient organisations, economists, authorities and industry.

Continuing Medical Education (CME) credit points will be awarded to physicians for the time they will spend at the meeting improving their knowledge and skills. ESH is a provider of the European Haematology CME system.

Posters and Brief Oral Communications:

Registered participants are invited to submit their clinical cases and abstracts abstracts. Selected clinical cases and abstracts will be presented as brief oral communications or posters.

Call for abstracts and clinical cases: deadline 2 July 2023

The meeting will be of interest to:

  • Senior biologists and clinicians, including experts in the field (MD, PhD, MD-PhD)
  • Junior scientists and clinicians (MD, PhD)
  • PhD candidates and clinical residents still in-training

Learning Objectives:

Upon completion of this CME activity, participants should be able to:

  • Understanding of the current landscape of bispecific antibodies
  • Understanding of the current landscape of CAR-T cells
  • Novel approaches and technologies in the field
  • Integration of novel therapies into current clinical practice
  • Future perspectives in bispecific antibody and cellular therapies in haematological malignancies and solid tumours Scientific

Topics:

  • Diffuse large B-cell Lymphoma: How to optimize the benefit of CAR T-cell therapy?
  • Diffuse large B-cell lymphoma: How to minimize potential risks of CAR T-cell therapy?
  • Multiple Myeloma: targeting BCMA with bispecifics and CARs
  • Bispecific antibodies in the treatment of B-NHL
  • Acute lymphoblastic leukaemia (ALL): the role of CARs and Bispecifics
  • Lessons from paediatric haematology
  • Perspectives: CARs and bispecifics for haematological malignancies

The programme will include:

  • Keynote Lecture
  • Plenary Sessions
  • Meet the Expert Sessions
  • Roundtables
  • Debates
  • Mentored Poster Walks
  • Brief Oral Communications
  • Voting technology

Conference website and registration

External Events

Aug 24
8
17
Sep 24
13
17
23
27
Oct 24
4
7
Nov 24
8
13
21
26
August 8th 2024
Pathology Summer School 2024
Annual event for UK medical students in any year of training.
Details
August 17th 2024
FRCPATH- 1 Exam Course
This is a popular 2 day intensive exam oriented course targeted towards haematology trainees aiming to sit their FRCP...
Details
September 13th 2024
Renal-Haematology Summit: Exploring Intersectio...
Join us for this multidisciplinary conference bringing together expert clinicians and researchers from Haematology an...
Details
September 17th 2024
Cambridge Lymphoma Biology International Sympos...
The third Cambridge Lymphoma Biology International Symposium will bring together research scientists and clinicians w...
Details
September 23rd 2024
Haematology in Obstetrics course 2024
The Haematology in Obstetrics course aims to develop an understanding of the physiology and pathology of obstetric ha...
Location: St Edmund Hall, Oxford University
Details
September 27th 2024
CAR-T for Autoimmune Disease
Dr Claire Roddie and UCLH CAR T team have organised this meeting to discuss CAR T cell therapy in the non-malignant d...
Details
October 4th 2024
National ALL Update Day
National ALL Update Day.
Details
October 7th 2024
UK CLL Forum Clinical Sciences Day
To educate healthcare professionals in aspects of CLL.
Details
November 8th 2024
UK Lymphoma Research Group
UK Lymphoma Research Group.
Details
November 13th 2024
BlooDHIT 2024
The Research & Development Department, Irish Blood Transfusion Service are holding its bi-annual conference in November.
Details
November 21st 2024
Introduction to Haematology Care
The Christie School of Oncology are going to be hosting a CPD accredited Introduction to Haematology Study Day that w...
Details
November 26th 2024
Current Thinking in Haematological Maligancies
Current Thinking in Haematological Malignancies.
Details